Article archive / July 1, 2014
Originally published: . Volume 5, No. 11. Source pages: 6.
The U.S. District Court in Lafayette ordered pharmaceutical firms Takeda and Eli Lilly to pay total of $9 billion in punitive damages based on conclusions that the firms may have covered up the cancer risks of the diabetes drug Actos.
U.S. District Judge Rebecca Doherty heard the case. The jury awarded $6 billion against Takeda and $3 billion against Eli Lilly. In addition, Allen was awarded $1.475 million in compensatory damages.
Kenneth D. Greisman, senior vice president and general counsel of Takeda Pharmaceuticals U.S.A. Inc., said the verdict would be appealed, according to several reports.
This article is part of a historical newspaper archive. Read the original issue for its original layout, photographs and graphics.